Topics

Glioblastoma | Treatment | Targeted therapy | Niraparib

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Niraparib

Cordell EC, Mansour M, Pantel AR, Schubert E, Nabavizadeh A, Mohan S, Maloney E, Prior T, Angeloni N, Blessing C, Frangos S, Coghlan L, Wileyto EP, O'Rourke DM, Brem S, Desai AS, Bagley SJ.
A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma.
Neurooncol Adv. 2026 Apr 20;8(1):vdag076. doi: 10.1093/noajnl/vdag076. PMID: 42058764. Trial registration ID: NCT04221503. ˍ